Rosacea and the subpurpuric pulsed dye laser treatment efficacy - a randomized controlled trial
Completed
- Conditions
- rosacea (subtype 1/erythematotelangiectatic): facial telangiectasia10014982
- Registration Number
- NL-OMON41694
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 64
Inclusion Criteria
Subject has erythematotelangiectatic rosacea with at least 5 telangiectasia.
Skintype I-III according to Fitzpatrick.
Exclusion Criteria
Subject is pregnant.
Presence of dermatoses that might interfere with the rosacea diagnosis or the evaluation of treatment results.
Subject has used isotretinoin six months prior to the first treatment session.
Subject is known to have a seizure disorder triggered by light.
Subject has suspicious pigmented lesions on the face.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>• Health Related Quality of Life (HRQoL) measurement as a patient reported<br /><br>outcome (PRO) by using the RosaQol, a rosacea-specific HRQoL questionnaire<br /><br>• Blinded evaluation of photographs: Investigators Global Assessment (IGA) </p><br>
- Secondary Outcome Measures
Name Time Method <p>• Patient*s Global Assessment (PGA)<br /><br>• Blinded evaluation of photographs: Clinician's Erythema Assessment (CEA) and<br /><br>grading the severity of telangiectasia</p><br>